GLP1R and diabetes mellitus: Notably, two studies controlled the dosage of GLP-1R agonists at a level that would not affect the blood glucose of in vivo DM models, and these two studies demonstrated that the neuroprotective effects of GLP-1R agonists are independent of their blood glucose-lowering effects.